{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:29:44Z","timestamp":1781105384338,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T00:00:00Z","timestamp":1466467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Carboxyl terminus of Hsp70-interacting protein (CHIP) is a critical ubiquitin ligase\/cochaperone to reduce cardiac oxidative stress, inflammation, cardiomyocyte apoptosis and autophage etc. However, it is unclear whether overexpression of CHIP in the heart would exert protective effects against DOX-induced cardiomyopathy. Cardiac-specific CHIP transgenic (CHIP-TG) mice and the wild-type (WT) littermates were treated with DOX or saline. DOX-induced cardiac atrophy, dysfunction, inflammation, oxidative stress and cardiomyocyte apoptosis were significantly attenuated in CHIP-TG mice. CHIP-TG mice also showed higher survival rate than that of WT mice (40% versus 10%) after 10-day administration of DOX. In contrast, knockdown of CHIP by siRNA <jats:italic>in vitro<\/jats:italic> further enhanced DOX-induced cardiotoxic effects. Global gene microarray assay revealed that after DOX-treatment, differentially expressed genes between WT and CHIP-TG mice were mainly involved in apoptosis, atrophy, immune\/inflammation and oxidative stress. Mechanistically, CHIP directly promotes ubiquitin-mediated degradation of p53 and SHP-1, which results in activation of ERK1\/2 and STAT3 pathways thereby ameliorating DOX-induced cardiac toxicity.<\/jats:p>","DOI":"10.1038\/srep28399","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T09:15:50Z","timestamp":1466500550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein"],"prefix":"10.1038","volume":"6","author":[{"given":"Lei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lian","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Min","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Long","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"key":"BFsrep28399_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2174\/187152508785909474","volume":"6","author":"AL Ferreira","year":"2008","unstructured":"Ferreira, A. L., Matsubara, L. S. & Matsubara, B. B. Anthracycline-induced cardiotoxicity. Cardiovascular & hematological agents in medicinal chemistry 6, 278\u2013281 (2008).","journal-title":"Cardiovascular & hematological agents in medicinal chemistry"},{"key":"BFsrep28399_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1016\/j.amjcard.2013.08.026","volume":"112","author":"M Lotrionte","year":"2013","unstructured":"Lotrionte, M. et al. Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. The American journal of cardiology 112, 1980\u20131984 (2013).","journal-title":"The American journal of cardiology"},{"key":"BFsrep28399_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/A:1007094214460","volume":"207","author":"PK Singal","year":"2000","unstructured":"Singal, P. K., Li, T., Kumar, D., Danelisen, I. & Iliskovic, N. Adriamycin-induced heart failure: mechanism and modulation. Molecular and cellular biochemistry 207, 77\u201386 (2000).","journal-title":"Molecular and cellular biochemistry"},{"key":"BFsrep28399_CR4","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1161\/CIRCULATIONAHA.105.598409","volume":"113","author":"YK Kim","year":"2006","unstructured":"Kim, Y. K. et al. Deletion of the inducible 70-kDa heat shock protein genes in mice impairs cardiac contractile function and calcium handling associated with hypertrophy. Circulation 113, 2589\u20132597 (2006).","journal-title":"Circulation"},{"key":"BFsrep28399_CR5","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/CIRCRESAHA.108.182832","volume":"103","author":"GC Fan","year":"2008","unstructured":"Fan, G. C. et al. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity. Circulation research 103, 1270\u20131279 (2008).","journal-title":"Circulation research"},{"key":"BFsrep28399_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.yjmcc.2009.05.016","volume":"47","author":"X Wang","year":"2009","unstructured":"Wang, X. et al. Overexpression of Hsp20 prevents endotoxin-induced myocardial dysfunction and apoptosis via inhibition of NF-kappaB activation. Journal of molecular and cellular cardiology 47, 382\u2013390 (2009).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"BFsrep28399_CR7","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1128\/MCB.19.6.4535","volume":"19","author":"CA Ballinger","year":"1999","unstructured":"Ballinger, C. A. et al. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 19, 4535\u20134545 (1999).","journal-title":"Mol Cell Biol"},{"key":"BFsrep28399_CR8","doi-asserted-by":"publisher","first-page":"27443","DOI":"10.1074\/jbc.M501574200","volume":"280","author":"C Esser","year":"2005","unstructured":"Esser, C., Scheffner, M. & Hohfeld, J. The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation. J Biol Chem 280, 27443\u201327448 (2005).","journal-title":"J Biol Chem"},{"key":"BFsrep28399_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/35050509","volume":"3","author":"GC Meacham","year":"2001","unstructured":"Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M. & Cyr, D. M. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 3, 100\u2013105 (2001).","journal-title":"Nat Cell Biol"},{"key":"BFsrep28399_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1379\/CSC-90R.1","volume":"10","author":"JR Hwang","year":"2005","unstructured":"Hwang, J. R., Zhang, C. & Patterson, C. C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis. Cell stress & chaperones 10, 147\u2013156 (2005).","journal-title":"Cell stress & chaperones"},{"key":"BFsrep28399_CR11","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1073\/pnas.0709180105","volume":"105","author":"CA Dickey","year":"2008","unstructured":"Dickey, C. A. et al. Akt and CHIP coregulate tau degradation through coordinated interactions. Proc Natl Acad Sci USA 105, 3622\u20133627 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep28399_CR12","doi-asserted-by":"publisher","first-page":"13829","DOI":"10.1074\/jbc.M209640200","volume":"278","author":"P Zhou","year":"2003","unstructured":"Zhou, P. et al. ErbB2 degradation mediated by the co-chaperone protein CHIP. J Biol Chem 278, 13829\u201313837 (2003).","journal-title":"J Biol Chem"},{"key":"BFsrep28399_CR13","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1128\/MCB.01737-08","volume":"29","author":"P Xie","year":"2009","unstructured":"Xie, P. et al. CHIP represses myocardin-induced smooth muscle cell differentiation via ubiquitin-mediated proteasomal degradation. Mol Cell Biol 29, 2398\u20132408 (2009).","journal-title":"Mol Cell Biol"},{"key":"BFsrep28399_CR14","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1093\/emboj\/cdg529","volume":"22","author":"Q Dai","year":"2003","unstructured":"Dai, Q. et al. CHIP activates HSF1 and confers protection against apoptosis and cellular stress. Embo J 22, 5446\u20135458 (2003).","journal-title":"Embo J"},{"key":"BFsrep28399_CR15","doi-asserted-by":"publisher","first-page":"H2836","DOI":"10.1152\/ajpheart.01122.2004","volume":"288","author":"C Zhang","year":"2005","unstructured":"Zhang, C., Xu, Z., He, X. R., Michael, L. H. & Patterson, C. CHIP, a cochaperone\/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 288, H2836\u20132842 (2005).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep28399_CR16","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/CIRCRESAHA.109.214346","volume":"106","author":"AT Naito","year":"2010","unstructured":"Naito, A. T. et al. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circulation research 106, 1692\u20131702 (2010).","journal-title":"Circulation research"},{"key":"BFsrep28399_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000343361","volume":"31","author":"CW Xu","year":"2013","unstructured":"Xu, C. W., Zhang, T. P., Wang, H. X., Yang, H. & Li, H. H. CHIP enhances angiogenesis and restores cardiac function after infarction in transgenic mice. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 31, 199\u2013208 (2013).","journal-title":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"BFsrep28399_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ajh.2012.74","volume":"25","author":"K Yang","year":"2012","unstructured":"Yang, K. et al. Carboxyl terminus of heat shock protein 70-interacting protein inhibits angiotensin II-induced cardiac remodeling. American journal of hypertension 25, 994\u20131001 (2012).","journal-title":"American journal of hypertension"},{"key":"BFsrep28399_CR19","doi-asserted-by":"crossref","unstructured":"Rose, B. A., Force, T. & Wang, Y. Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiological reviews 90, 1507\u20131546.","DOI":"10.1152\/physrev.00054.2009"},{"key":"BFsrep28399_CR20","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1161\/CIRCRESAHA.109.214346","volume":"106","author":"AT Naito","year":"2010","unstructured":"Naito, A. T. et al. Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury. Circulation research 106, 1692\u20131702 (2010).","journal-title":"Circulation research"},{"key":"BFsrep28399_CR21","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1182\/blood-2006-04-017434","volume":"108","author":"Y Han","year":"2006","unstructured":"Han, Y. et al. Loss of SHP-1 enhances JAK3\/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood 108, 2796\u20132803 (2006).","journal-title":"Blood"},{"key":"BFsrep28399_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cardiores.2005.05.031","volume":"68","author":"DI Palen","year":"2005","unstructured":"Palen, D. I., Belmadani, S., Lucchesi, P. A. & Matrougui, K. Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1\/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells. Cardiovasc Res 68, 268\u2013277 (2005).","journal-title":"Cardiovasc Res"},{"key":"BFsrep28399_CR23","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia, Y. et al. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. Journal of molecular and cellular cardiology 52, 1213\u20131225 (2012).","journal-title":"Journal of molecular and cellular cardiology"},{"key":"BFsrep28399_CR24","doi-asserted-by":"publisher","first-page":"H933","DOI":"10.1152\/ajpheart.00759.2003","volume":"286","author":"X Liu","year":"2004","unstructured":"Liu, X. et al. Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 286, H933\u2013939 (2004).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep28399_CR25","doi-asserted-by":"publisher","first-page":"e58421","DOI":"10.1371\/journal.pone.0058421","volume":"8","author":"S Toldo","year":"2013","unstructured":"Toldo, S. et al. Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse. PloS one 8, e58421 (2013).","journal-title":"PloS one"},{"key":"BFsrep28399_CR26","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1172\/JCI118909","volume":"98","author":"HC Yen","year":"1996","unstructured":"Yen, H. C., Oberley, T. D., Vichitbandha, S. & Ho, Y. S. & St Clair, D. K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. The Journal of clinical investigation 98, 1253\u20131260 (1996).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep28399_CR27","doi-asserted-by":"publisher","first-page":"12610","DOI":"10.1074\/jbc.271.21.12610","volume":"271","author":"YJ Kang","year":"1996","unstructured":"Kang, Y. J., Chen, Y. & Epstein, P. N. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J Biol Chem 271, 12610\u201312616 (1996).","journal-title":"J Biol Chem"},{"key":"BFsrep28399_CR28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1124\/jpet.105.099499","volume":"317","author":"R Greupink","year":"2006","unstructured":"Greupink, R. et al. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo . The Journal of pharmacology and experimental therapeutics 317, 514\u2013521 (2006).","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"BFsrep28399_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1203\/PDR.0b013e318184d732","volume":"64","author":"W Zhu","year":"2008","unstructured":"Zhu, W., Shou, W., Payne, R. M., Caldwell, R. & Field, L. J. A mouse model for juvenile doxorubicin-induced cardiac dysfunction. Pediatric research 64, 488\u2013494 (2008).","journal-title":"Pediatric research"},{"key":"BFsrep28399_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.105.568402","volume":"113","author":"L Li","year":"2006","unstructured":"Li, L. et al. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation 113, 535\u2013543 (2006).","journal-title":"Circulation"},{"key":"BFsrep28399_CR31","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.87.11.4275","volume":"87","author":"H Ito","year":"1990","unstructured":"Ito, H. et al. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro . Proc Natl Acad Sci USA 87, 4275\u20134279 (1990).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep28399_CR32","first-page":"556","volume":"31","author":"FJ Pashkow","year":"2006","unstructured":"Pashkow, F. J. Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and\/or Prevention? International journal of inflammation 31, 556\u2013559 (2006).","journal-title":"International journal of inflammation"},{"key":"BFsrep28399_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-005-5905-8","volume":"273","author":"Y Shizukuda","year":"2005","unstructured":"Shizukuda, Y., Matoba, S., Mian, O. Y., Nguyen, T. & Hwang, P. M. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Molecular and cellular biochemistry 273, 25\u201332 (2005).","journal-title":"Molecular and cellular biochemistry"},{"key":"BFsrep28399_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/labinvest.3700530","volume":"87","author":"L Li","year":"2007","unstructured":"Li, L. et al. Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy. Laboratory investigation; a journal of technical methods and pathology 87, 440\u2013455 (2007).","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"key":"BFsrep28399_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI29715","volume":"117","author":"CA Dickey","year":"2007","unstructured":"Dickey, C. A. et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. The Journal of clinical investigation 117, 648\u2013658 (2007).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep28399_CR36","doi-asserted-by":"publisher","first-page":"12144","DOI":"10.1074\/jbc.M200102200","volume":"277","author":"MJ Piatelli","year":"2002","unstructured":"Piatelli, M. J., Doughty, C. & Chiles, T. C. Requirement for a hsp90 chaperone-dependent MEK1\/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes. The Journal of biological chemistry 277, 12144\u201312150 (2002).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep28399_CR37","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1038\/emboj.2010.141","volume":"29","author":"T Maruyama","year":"2010","unstructured":"Maruyama, T. et al. CHIP-dependent termination of MEKK2 regulates temporal ERK activation required for proper hyperosmotic response. The EMBO journal 29, 2501\u20132514 (2010).","journal-title":"The EMBO journal"},{"key":"BFsrep28399_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/157488707781662715","volume":"2","author":"DF Calvisi","year":"2007","unstructured":"Calvisi, D. F., Pascale, R. M. & Feo, F. Dissection of signal transduction pathways as a tool for the development of targeted therapies of hepatocellular carcinoma. Reviews on recent clinical trials 2, 217\u2013236 (2007).","journal-title":"Reviews on recent clinical trials"},{"key":"BFsrep28399_CR39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4161\/jkst.21560","volume":"1","author":"S Hatakeyama","year":"2012","unstructured":"Hatakeyama, S. Ubiquitin-mediated regulation of JAK-STAT signaling in embryonic stem cells. Jak-Stat 1, 168\u2013175 (2012).","journal-title":"Jak-Stat"},{"key":"BFsrep28399_CR40","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.2174\/0929867321666140414100831","volume":"21","author":"I Kolosenko","year":"2014","unstructured":"Kolosenko, I., Grander, D. & Tamm, K. P. IL-6 activated JAK\/STAT3 pathway and sensitivity to Hsp90 inhibitors in multiple myeloma. Current medicinal chemistry 21, 3042\u20133047 (2014).","journal-title":"Current medicinal chemistry"},{"key":"BFsrep28399_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.tips.2012.08.005","volume":"33","author":"LM LaFave","year":"2012","unstructured":"LaFave, L. M. & Levine, R. L. JAK2 the future: therapeutic strategies for JAK-dependent malignancies. Trends in pharmacological sciences 33, 574\u2013582 (2012).","journal-title":"Trends in pharmacological sciences"},{"key":"BFsrep28399_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1073\/pnas.97.1.315","volume":"97","author":"K Kunisada","year":"2000","unstructured":"Kunisada, K. et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA 97, 315\u2013319 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep28399_CR43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/0092-8674(95)90351-8","volume":"80","author":"U Klingmuller","year":"1995","unstructured":"Klingmuller, U., Lorenz, U., Cantley, L. C., Neel, B. G. & Lodish, H. F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80, 729\u2013738 (1995).","journal-title":"Cell"},{"key":"BFsrep28399_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/smim.2000.0223","volume":"12","author":"J Zhang","year":"2000","unstructured":"Zhang, J., Somani, A. K. & Siminovitch, K. A. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Seminars in immunology 12, 361\u2013378 (2000).","journal-title":"Seminars in immunology"},{"key":"BFsrep28399_CR45","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1128\/IAI.00853-05","volume":"74","author":"G Forget","year":"2006","unstructured":"Forget, G., Gregory, D. J., Whitcombe, L. A. & Olivier, M. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect Immun 74, 6272\u20136279 (2006).","journal-title":"Infect Immun"},{"key":"BFsrep28399_CR46","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/ni.1604","volume":"9","author":"H An","year":"2008","unstructured":"An, H. et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol 9, 542\u2013550 (2008).","journal-title":"Nat Immunol"},{"key":"BFsrep28399_CR47","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1172\/JCI200422220","volume":"114","author":"HH Li","year":"2004","unstructured":"Li, H. H. et al. Atrogin-1\/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. The Journal of clinical investigation 114, 1058\u20131071 (2004).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep28399_CR48","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/cvr\/cvt258","volume":"101","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. Cardiovasc Res 101, 383\u2013392 (2014).","journal-title":"Cardiovasc Res"},{"key":"BFsrep28399_CR49","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.febslet.2009.07.006","volume":"583","author":"D Yang","year":"2009","unstructured":"Yang, D., Guo, S., Zhang, T. & Li, H. Hypothermia attenuates ischemia\/reperfusion-induced endothelial cell apoptosis via alterations in apoptotic pathways and JNK signaling. FEBS letters 583, 2500\u20132506 (2009).","journal-title":"FEBS letters"},{"key":"BFsrep28399_CR50","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/cvr\/cvp323","volume":"85","author":"D Yang","year":"2010","unstructured":"Yang, D., Xie, P., Guo, S. & Li, H. Induction of MAPK phosphatase-1 by hypothermia inhibits TNF-alpha-induced endothelial barrier dysfunction and apoptosis. Cardiovasc Res 85, 520\u2013529 (2010).","journal-title":"Cardiovasc Res"},{"key":"BFsrep28399_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12012-014-9306-7","volume":"15","author":"SN Wei","year":"2015","unstructured":"Wei, S. N. et al. Microarray and Co-expression Network Analysis of Genes Associated with Acute Doxorubicin Cardiomyopathy in Mice. Cardiovascular toxicology 15, 377\u2013393 (2015).","journal-title":"Cardiovascular toxicology"},{"key":"BFsrep28399_CR52","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/0006-2952(92)90132-3","volume":"44","author":"D Bonnes-Taourel","year":"1992","unstructured":"Bonnes-Taourel, D., Guerin, M. C. & Torreilles, J. Is malonaldehyde a valuable indicator of lipid peroxidation? Biochemical pharmacology 44, 985\u2013988 (1992).","journal-title":"Biochemical pharmacology"},{"key":"BFsrep28399_CR53","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng1201-365","volume":"29","author":"A Brazma","year":"2001","unstructured":"Brazma, A. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature genetics 29, 365\u2013371 (2001).","journal-title":"Nature genetics"},{"key":"BFsrep28399_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tox.2015.04.009","volume":"333","author":"WJ Zhao","year":"2015","unstructured":"Zhao, W. J. et al. Gene expression profiling identifies the novel role of immunoproteasome in doxorubicin-induced cardiotoxicity. Toxicology 333, 76\u201388 (2015).","journal-title":"Toxicology"},{"key":"BFsrep28399_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00540-013-1568-x","volume":"27","author":"Z Wajima","year":"2013","unstructured":"Wajima, Z., Shiga, T., Imanaga, K. & Inoue, T. Vigilance of hemodynamic changes immediately after transferring patients is crucial. Journal of anesthesia 27, 521\u2013527 (2013).","journal-title":"Journal of anesthesia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep28399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28399","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep28399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:23:40Z","timestamp":1672896220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep28399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,6,30]]}},"alternative-id":["BFsrep28399"],"URL":"https:\/\/doi.org\/10.1038\/srep28399","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,21]]},"assertion":[{"value":"14 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28399"}}